Search Results - "Schottelius, D D"

Refine Results
  1. 1

    Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS) : correlation with phenobarbital adsorption data by BURKE, G. M, WURSTER, D. E, BERG, M. J, VENG-PEDERSEN, P, SCHOTTELIUS, D. D

    Published in Pharmaceutical research (1992)
    “…X-ray photoelectron spectroscopy (XPS) was used to identify the functional states of carbon existing on the surfaces of various activated charcoals. The…”
    Get full text
    Journal Article
  2. 2

    Phenytoin pharmacokinetics: before and after folic acid administration by Berg, M J, Fincham, R W, Ebert, B E, Schottelius, D D

    Published in Epilepsia (Copenhagen) (01-07-1992)
    “…Phenytoin (PHT) exhibits linear and Michaelis-Menten pharmacokinetics. PHT decreases serum folate; the vitamin folic acid (FA) is hypothesized to be a cofactor…”
    Get more information
    Journal Article
  3. 3

    Model selection for the adsorption of phenobarbital by activated charcoal by BURKE, G. M, WURSTER, D. E, BURAPHACHEEP, V, BERG, M. J, VENG-PEDERSEN, P, SCHOTTELIUS, D. D

    Published in Pharmaceutical research (01-02-1991)
    “…Activated charcoal is known to adsorb a wide variety of substances from solution, and several equations have been used to fit the resulting adsorption data…”
    Get full text
    Journal Article
  4. 4

    Phenobarbital removal characteristics of three brands of activated charcoals : a system analysis approach by MODI, N. B, VENG-PEDERSEN, P, WURSTER, D. E, BERG, M. J, SCHOTTELIUS, D. D

    Published in Pharmaceutical research (01-02-1994)
    “…The in vivo phenobarbital removal characteristics of three brands of activated charcoal (Actidose, Charcoaid, Superchar) were studied in normal volunteers…”
    Get full text
    Journal Article
  5. 5

    Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital by Berg, M J, Rose, J Q, Wurster, D E, Rahman, S, Fincham, R W, Schottelius, D D

    Published in Therapeutic drug monitoring (01-03-1987)
    “…The effects of two different oral charcoal suspensions on the elimination of a 200 mg/70 kg, 1 h intravenous (i.v.) infusion of phenobarbital and the…”
    Get more information
    Journal Article
  6. 6

    Decrease of serum folates in healthy male volunteers taking phenytoin by Berg, M J, Fincham, R W, Ebert, B E, Schottelius, D D

    Published in Epilepsia (Copenhagen) (01-01-1988)
    “…The effect of phenytoin (PHT) on serum folate and the effect of additional oral folic acid (FA) on serum folate during continued treatment with PHT were…”
    Get more information
    Journal Article
  7. 7

    Phenobarbital adsorption from simulated intestinal fluid U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals by WURSTER, D. E, BURKE, G. M, BERG, M. J, VENG-PEDERSEN, P, SCHOTTELIUS, D. D

    Published in Pharmaceutical research (01-03-1988)
    “…Adsorption of phenobarbital from simulated intestinal and gastric fluids by two activated charcoals was studied. Adsorption isotherm data were analyzed by the…”
    Get full text
    Journal Article
  8. 8

    Utilization of Km for phenytoin dosage after folate addition to patient regimen by Berg, M J, Ebert, B E, Rivey, M P, Schottelius, D D

    Published in Therapeutic drug monitoring (01-09-1987)
    “…Phenytoin decreases serum and red blood cell folates in 50% of the patients on the anticonvulsant. The supplementation of folic acid changes the disposition of…”
    Get more information
    Journal Article
  9. 9

    Phenytoin binding in healthy volunteers by Berg, M J, Ebert, B E, Fincham, R W, Schottelius, D D

    Published in Therapeutic drug monitoring (01-12-1987)
    “…The pharmacologic effect of phenytoin is directly related to the unbound concentration in the serum, which previously has been reported in the literature to be…”
    Get more information
    Journal Article
  10. 10

    Phenytoin-folic acid: a review by Rivey, M P, Schottelius, D D, Berg, M J

    Published in Drug intelligence & clinical pharmacy (01-04-1984)
    “…The nutrient-drug interaction between folate and phenytoin is a two-way interaction. Folate deficiency resulting from long-term phenytoin therapy is a common…”
    Get more information
    Journal Article
  11. 11

    Folic Acid improves Phenytoin Pharmacokinetics by BERG, MARY J, STUMBO, PHYLLIS J, CHENARD, CATHERINE A, FINCHAM, RICHARD W, SCHNEIDER, PHILIP J, SCHOTTELIUS, DOROTHYD

    “…Phenytoin (PHT) therapy to control seizures decreases serum folate levels in half of epileptic patients, thus increasing the risk of folate depletion…”
    Get full text
    Journal Article
  12. 12

    Phenytoin and folic acid: individualized drug-drug interaction by Berg, M J, Rivey, M P, Vern, B A, Fischer, L J, Schottelius, D D

    Published in Therapeutic drug monitoring (01-01-1983)
    “…The effect of folic acid supplementation on the disposition of phenytoin and the resultant loss of seizure control in a male folate-deficient epileptic is…”
    Get more information
    Journal Article
  13. 13

    Phenytoin and folic acid interaction: a preliminary report by Berg, M J, Fischer, L J, Rivey, M P, Vern, B A, Lantz, R K, Schottelius, D D

    Published in Therapeutic drug monitoring (01-01-1983)
    “…The effect of folic acid (1 mg/day orally) on phenytoin steady-state pharmacokinetics was studied in four male folate-deficient epileptic patients who were…”
    Get more information
    Journal Article
  14. 14

    Decreased phenytoin levels in antineoplastic therapy by Fincham, R W, Schottelius, D D

    Published in Therapeutic drug monitoring (1979)
    “…A case history is reported illustrating the difficulties which may be encountered in maintaining seizure control in patients being treated with antineoplastic…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Optimization of pharmacokinetic monitoring: I. Linear pharmacokinetics by Berg, M J, Lantz, R K, Schoenwald, R D, Clarke, M I, Schottelius, D D

    Published in Therapeutic drug monitoring (1983)
    “…To reach and maintain therapeutic drug concentrations, reliable estimates of the parameters describing the pharmacokinetic behavior of the drug are required…”
    Get more information
    Journal Article
  17. 17

    Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal by Gillespie, W R, Veng-Pedersen, P, Berg, M J, Schottelius, D D

    “…The theory of linear systems analysis is applied to the evaluation of induced drug removal processes. The rate and extent of removal are determined by…”
    Get more information
    Journal Article
  18. 18

    Use of phenytoin serum levels in a case of status epilepticus by Fincham, R W, Wiley, D E, Schottelius, D D

    Published in Neurology (01-09-1976)
    “…Serum anticonvulsant determinations made possible the identification of an unusual cause of status epilepticus and assisted with appropriate therapy in an…”
    Get full text
    Journal Article
  19. 19

    Parkinsonism--drug treatment: Part I by Berg, M J, Ebert, B, Willis, D K, Host, T, Fincham, R W, Schottelius, D D

    Published in Drug intelligence & clinical pharmacy (01-01-1987)
    “…The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the…”
    Get more information
    Journal Article
  20. 20